Dr Joshua Sopp
Dr Joshua Sopp gained his PhD in experimental cancer biology at the University of Southampton, before holding research positions at Ipsen and Revona Bio, where he developed antibody therapeutics and high-throughput screening assays for RNA-selective compounds. Now at Promega UK, Josh manages the HiBiT protein tagging portfolio, plate readers and bioluminescence imaging systems.
Contact info
- Website:
- https://www.promega.co.uk/
ArticleSmall tags, big advances: studying endogenous proteins in their native context
By combining CRISPR knock-in with small peptide tags, researchers can study proteins in their native cellular context, generating more predictive data for translational drug discovery.